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Individual genetic background together with environmental effects are thought to be
behind many human complex diseases. A number of genetic variants, mainly single
nucleotide polymorphisms (SNPs), have been shown to be associated with various
pathological and inflammatory conditions, representing potential therapeutic targets.
Prostaglandins (PTGs) and leukotrienes (LTs) are eicosanoids derived from arachidonic
acid and related polyunsaturated fatty acids that participate in both normal homeostasis
and inflammatory conditions. These bioactive lipid mediators are synthesized through
two major multistep enzymatic pathways: PTGs by cyclooxygenase and LTs by
5-lipoxygenase. The main physiological effects of PTGs include vasodilation and vascular
leakage (PTGE2); mast cell maturation, eosinophil recruitment, and allergic responses
(PTGD2); vascular and respiratory smooth muscle contraction (PTGF2), and inhibition of
platelet aggregation (PTGI2). LTB4 is mainly involved in neutrophil recruitment, vascular
leakage, and epithelial barrier function, whereas cysteinyl LTs (CysLTs) (LTC4, LTD4, and
LTE4) induce bronchoconstriction and neutrophil extravasation, and also participate in
vascular leakage. PTGs and LTs exert their biological functions by binding to cognate
receptors, which belong to the seven transmembrane, G protein-coupled receptor
superfamily. SNPs in genes encoding these receptors may influence their functionality
and have a role in disease susceptibility and drug treatment response. In this review we
summarize SNPs in PTGs and LTs receptors and their relevance in human diseases. We
also provide information on gene expression. Finally, we speculate on future directions
for this topic.
Keywords: prostaglandins, leukotrienes, eicosanoid receptors polymorphisms, inflammation,
NSAID-hypersensitivity
INTRODUCTION
Arachidonic acid is released from cell membrane phospholipids by phospholipase A2 in response to
different stimuli, and then oxidized through cyclooxygenase (COX)-1 or 5-lipoxygenase (5LO) to
produce prostaglandins (PTGs) and leukotrienes (LTs), respectively (Capra et al., 2015). Although
these bioactive lipid mediators, collectively named eicosanoids, are associated with homeostasis
they also play a key role in inflammation.
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The COX-1 pathway firstly leads to the formation of
prostanoids with the PTGH2 endoperoxide intermediate,
that is metabolized to PTGD2, PTGE2, PTGF2a, PTGI2,
and thromboxane (TX)A2 by specific synthases. The main
physiological effects of PTGs include vasodilation and vascular
leakage (PTGE2); mast cell maturation, eosinophil recruitment
and allergic responses (PTGD2); vascular and respiratory
smooth muscle contraction (PTGF2), and inhibition of platelet
aggregation (PTGI2) (Claar et al., 2015).
LTs can be grouped into the chemoattractant LTB4 and
the cysteinyl LTs (CysLTs): LTC4, LTD4, and LTE4. LTB4 is
mainly involved in neutrophil recruitment, vascular leakage,
and epithelial barrier function, whereas CysLTs induce
bronchoconstriction and neutrophil extravasation, and also
participate in vascular leakage (Singh et al., 2013).
PTGs and LTs exert their biological functions by binding
to cognate receptors belonging to the seven transmembrane
G protein-coupled receptor superfamily (GPCRs): PTGFR and
PTGIR for PTGF and PTGI2, respectively; PTGDR and CRTH2
(chemoattractant receptor-homologous molecule expressed on
Th2 cells) for PTGD; PTGER1 to PTGER4 for PTGE; and TXA2R
for TXA2 (Thompson et al., 2014). LTB receptors are BLTR1 and
BLTR2, and CysLTR1 and CysLTR2 for CysLTs.
In addition to the environment, human complex diseases are
also affected by individual factors including genetic background.
In fact, a number of genetic variants, mainly single nucleotide
polymorphisms (SNPs), have been consistently associated with
different pathological and inflammatory conditions, representing
potential targets for therapy. SNPs in genes encoding PTG and
LT receptors may influence their functionality and have a role
in disease susceptibility and treatment response. In this review
we summarize current knowledge regarding SNPs in PTGs and
LTs receptors and their association with human inflammatory
conditions (Table 1), with a special focus on hypersensitivity
to non-steroidal anti-inflammatory drugs (NSAIDs), the most
common type of drug hypersensitivity.
PTG, TBXA2, AND LT RECEPTOR
POLYMORPHISMS IN INFLAMMATORY
CONDITIONS
PTGFR, PTGIR, PTGDR, and CRTH2
Current data concerning PTGFR genetic variation supports its
relationship with variability in treatment response to latanoprost,
a commonly prescribed antiglaucomatous drug, although the
mechanisms underlying this association are unknown (Gao et al.,
2015; Ussa et al., 2015).
PTGI2 (prostacyclin) plays a key role in the cardiovascular
system through the specific inhibition of platelet aggregation
and its vasodilatory effects on smooth muscle (Dorris and
Peebles, 2012). The polymorphism A984C in PTGIR has been
associated with platelet aggregation and may play a role in
cerebral infarction (Shimizu et al., 2013). Two synonymous
variants in this gene (V53V and S328S) have also been associated
with enhanced platelet activation in patients with deep vein
thrombosis (Patrignani et al., 2008).
An important genomic region on chromosome 14 that
includes PTGDR has been linked to asthma and atopy (1997;
Mansur et al., 1999; Hakonarson et al., 2002). There are
conflicting results concerning the association of promoter
variants influencing the transcription of this gene with these
phenotypes. For example, some studies have failed to associate
two variants in PTGDR (−441C>T and −197TC>T) with
asthma using family-based or case-control analyses in Latinos
and African American asthmatics (Tsai et al., 2006). In addition,
particular PTGDR haplotypes could not be associated with
Chinese children with asthma and atopy (Leung et al., 2009),
or with two Australian populations of asthmatics (Jamrozik
et al., 2011), with similar data having been previously reported
in a distinct Chinese population (Li et al., 2007). However,
−441C>T, −197TC>T, −549T>C, and various haplotypes
have been associated with asthma in two ethnically different
populations (Oguma et al., 2004). Moreover, the −197T >C and
−613C >T polymorphisms have been significantly associated
with allergic asthma, and allergy to pollen and mites, respectively
(Isidoro-García et al., 2011). The same authors also found
that the PTGDR diplotype CCCT/CCCC (−613CC, −549CC,
−441CC, and −197TC), with a potential influence on gene
transcription, was more frequent in patients with nasal polyposis,
with or without asthma, and in patients suffering from the
aspirin triad (Benito Pescador et al., 2012). In addition to these
SNPs in PTGDR, the promoter polymorphism −731A>G and
the intronic variant 6651C>T were found to be associated
with asthma, atopic asthma, and bronchial hyperreactivity in
families from UK, with similar results for 6651C>T in a Danish
study (Zhu et al., 2007). The intronic variants rs17831675 and
rs17831682 in PTGDR have also been associated with asthma
susceptibility (Ungvári et al., 2012). These variants, as well as
rs17125273, also appear to have some relevance with respect to
IgE levels in asthmatics (Ungvári et al., 2012).
Different studies have shown certain polymorphisms in
CRTH2 (rs11571288, rs545659, and rs634681) to be associated
with asthma and allergic sensitization in different populations
(Huang et al., 2004; Cameron et al., 2009; Wang et al., 2009).
A functional study showed that in addition to being linked
with asthma, the 1544G–1651G haplotype in the CRTH2 3′-
UTR increased mRNA stability, supporting its role as a strong
candidate gene for asthma (Huang et al., 2004). In another study
the rs533116 variant was associated with a higher proportion of
CRTh2 cells during Th2 differentiation as well as increased IL-
4 and IL-13 expression levels after agonist stimulation (Campos
Alberto et al., 2012). The minor allele of CRTH2 1431G>C has
been also associated with levels of specific IgE to food allergens in
a population of German children (Cameron et al., 2009).
PTGE Receptors
Considering the great variety of biological functions carried out
by PTGE it is not surprising that SNPs in its receptors appear
to have a role in different pathologies. For example, the rs17197
polymorphism in the 3′-UTR of PTGER2 has been associated
with essential hypertension in men (Sato et al., 2007), and the
intronic rs2268062 variant in PTGER3 with hypertension in a
separate study (Sõber et al., 2009). The latter may be explained
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TABLE 1 | Main prostaglandin and leukotriene polymorphisms associated with different human inflammatory conditions.
Gene Polymorphism Condition Population References
Prostaglandin I2
receptor (PTGIR)
A984C Cerebral infarction Japanese Shimizu et al., 2013
V53V, S328S Deep vein thrombosis Italian Patrignani et al., 2008
1915T>C NERD Korean Thompson et al., 2007
Prostaglandin D2
receptor (PTGDR)
−441C>T, −549T>C, and
−197T>C haplotypes
Asthma American Oguma et al., 2004
−613C>T Allergy to pollen and mites Spanish Isidoro-García et al., 2011
−197T>C Allergic asthma Spanish Isidoro-García et al., 2011
−613C>T, −549T>C,
−441C>T, and −197T>C
diplotype
Nasal polyposis with and without
asthma, and aspirin triad
Spanish Benito Pescador et al.,
2012
−731A>G, 6651C>T Asthma, atopic asthma, and
bronchial hyperreactivity
British and Danish Zhu et al., 2007
rs8004654 NIUA Spanish Cornejo-Garcia et al., 2012
Prostaglandin D2
receptor 2 (CRTH2)
1544G>C, 1651A>G Asthma and IL13 levels Chinese Wang et al., 2009
1538A>G Food allergy sensitization German Cameron et al., 2009
−466T>C NERD Korean, and Japanese Palikhe et al., 2010;
Kohyama et al., 2012
−466T>C Antihistamine requirements in
chronic urticaria
Korean Palikhe et al., 2009
Prostaglandin E
receptor 1 (PTGER1)
1544G>C, 1651A>G Asthma African American, Chinese Huang et al., 2004
rs3810253, rs3810255 NERD Spanish Ayuso et al., 2015
Prostaglandin E
receptor 2 (PTGER2)
rs17197 Essential hypertension Japanese Sato et al., 2007
−616C>G, −166G>A NERD Korean Kim et al., 2007b
rs1254598 NERD Spanish Ayuso et al., 2015
Prostaglandin E
receptor 3 (PTGER3)
rs977214 Protective effect in preterm birth Norwegian Ryckman et al., 2010
1388T>C Increased asthma risk Korean Park et al., 2007
Prostaglandin E
receptor 4 (PTGER4)
rs7720838 Crohn disease American and German, German Glas et al., 2012; Prager
et al., 2014
rs4434423 Primary graft dysfunction Multicentered cohort including
different ethnicities
Diamond et al., 2014
rs10440635 Ankylosing spondylitis Han Chinese Chai et al., 2013
−1254G>A NERD Korean Kim et al., 2007b
rs13186505, rs4133101 NIUA Spanish Cornejo-Garcia et al., 2012
rs4495224 NERD Spanish Ayuso et al., 2015
−1254G>A NECD Korean Palikhe et al., 2012
Thromboxane A2
receptor (TBXA2R)
rs768963 Cerebral infarction Han Chinese Shao et al., 2015
rs768963 Cerebral infarction, large artery
atherosclerosis, and small artery
occlusion subtype.
Chinese Zhao et al., 2013
795T>C NERD Korean, Japanese Kim et al., 2007b;
Kohyama et al., 2012
(Continued)
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TABLE 1 | Continued
Gene Polymorphism Condition Population References
Cysteinyl leukotriene
receptor 1 (CYSLTR1)
G300S Atopy and asthma Tristan da Cunha Thompson et al., 2007
634C>T NECD Korean Kim et al., 2007a
rs320995 Asthma Spanish Arriba-Mendez et al., 2006
927T>C Atopy severity British Hao et al., 2006
rs320995 NIUA Spanish Cornejo-Garcia et al., 2012
−634C>T, −475A>C,
−336A>G
NERD Korean Kim et al., 2006
−634C>T NERD Korean Kim et al., 2007c
Cysteinyl leukotriene
receptor 2 (CYSLTR2)
M201V Atopy Tristan da Cunha Thompson et al., 2003
601A>G Asthma Danish and American Pillai et al., 2004
−1220A>C Asthma Japanese Fukai et al., 2004
rs320995 NERD Spanish Ayuso et al., 2015
−819T>G, 2078C>T, 2534A>G NERD Korean Park et al., 2005
NECD, non-steroidal anti-inflammatory drugs-exacerbated cutaneous disease; NERD, non-steroidal anti-inflammatory drugs-exacerbated respiratory disease; NIUA; non-steroidal
anti-inflammatory drugs-induced urticaria/angioedema.
by the role of this gene in neurotransmitter release modulation in
central and peripheral neurons, and in the inhibition of sodium
and water reabsorption in kidney (Breyer and Breyer, 2000).
A protective effect in preterm birth has been suggested for the
minor allele of rs977214 in PTGER3 (Ryckman et al., 2010).
Concerning asthma, a Bayesian analysis found an association
for several SNPs in PTGER2 (rs12587410, rs17197, rs1254600,
rs708498) (Ungvári et al., 2012). A Korean study showed
the promoter variant rs207579 (−616C>G) in PTGER2 to be
associated with increased asthma risk whereas two variants in the
3′-UTR of PTGER3 (rs959 and rs34745168) were associated with
a diminished risk (Park et al., 2007).
Environmental and genetic determinants affecting PTGER4
expression might be thought to be crucial in a plethora of
diseases, giving the central role of its ligand, PTGE2, in
immunomodulation and control of inflammation (Soontrapa
et al., 2011; Tang et al., 2012; Konya et al., 2013). For example, it
has been shown for Crohn’s disease that disease-associated alleles
in a gene-desert region in 5p13.1 correlate with expression levels
of PTGER4, the closest gene to this region (Libioulle et al., 2007).
Through a meta-analysis of genome wide association studies and
replication studies, rs11742570 in PTGER4 was recently found
to be associated with inflammatory bowel disease (Jostins et al.,
2012).
Two polymorphisms in PTGER4 (rs4495224 and rs7720838)
have been associated with susceptibility to Crohn’s disease in
three independent cohorts (Glas et al., 2012). Using in silico
analysis the authors predicted these SNPs to be crucial
components of binding sites for the transcription factors NF-
κB and XBP1 with higher binding scores for carriers of the
risk alleles, which could explain how these SNPs contribute
to increased PTGER4 expression (Glas et al., 2012). Notably,
the association of PTGER4 rs7720838 with Crohn’s disease has
recently been replicated in other populations (Prager et al., 2014).
Although the molecular link between genetic variation and
altered regulatory T cell function in primary graft dysfunction
has not been uncovered, a recent study showed the major allele
of the rs4434423 variant in PTGER4 to be associated with their
differential suppressive functions in this pathology (Diamond
et al., 2014).
Finally, another SNP in PTGER4 (rs10440635) has been
associated with ankylosing spondylitis severity in a Han Chinese
population (Chai et al., 2013).
TXA2R
TXA2R plays a central role in atherosclerosis and thrombosis
(Capra et al., 2014). It has been recently demonstrated that
the promoter polymorphism rs768963 is more frequent among
Han Chinese who have suffered from cerebral infarction (Shao
et al., 2015). Cells containing two exonic variants (C795T
and T924C) showed an increased ligand binding-induced
intracellular calcium influx and fibrinogen-integrin conjugation,
suggesting that TXA2R SNPs may influence platelet function and
the risk of developing cerebral ischemia (Shao et al., 2015). In
another study the C allele of rs768963 was associated with large
artery atherosclerosis and small artery occlusion subtypes (Zhao
et al., 2013).
The variants V80E and A160T in TBXA2R showed opposing
roles on platelet activity, inhibiting and promoting platelet
activation respectively (Gleim et al., 2013). The TBXA2R 924TT
genotype has been associated with residual platelet activity after
off-pump artery bypass grafting (Wang et al., 2013), and with
resistance to aspirin (Gao et al., 2011). This genotype also showed
less effectiveness in platelet aggregation (Fujiwara et al., 2007).
Homozygosity for the minor allele of the C795T, C924T or
the G1686A TBXA2R SNPs was associated with a decreased
expression of CD62P in agonist stimulated platelets (Fontana
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et al., 2006). Finally, the TBXA2R SNP rs13306046 was associated
with decreased blood pressure (Nossent et al., 2011).
A recent meta-analysis has shown an association between
the TBXA2R 924C>T polymorphism and asthma (Pan et al.,
2016). Asthmatic children with combinations of the TBXA2R
795T>C and 924T>C risk alleles had higher total IgE levels,
total eosinophil counts, and lower FEV1 than those carrying the
common alleles (Kim et al., 2008). The minor allele frequency
of TBXA2R 795T>C was significantly higher in NSAIDs-
exacerbated respiratory disease (NERD) patients compared with
aspirin-tolerant asthmatics and homozygous patients for the C
allele had a greater percent fall of FEV1 compared with carriers
of the CT or TT genotypes (Kim et al., 2005). A significant
association was also observed between the TBXA2R T924C
polymorphism and FEV1 in children with atopic asthma (Leung
et al., 2002; Hong et al., 2005).
Two haplotypes involving four intronic SNPs (rs2238631,
rs2238632, rs2238633, and rs2238634) influenced transcriptional
activity and were associated with asthma-related phenotypes
(Takeuchi et al., 2013). These SNPs are in linkage disequilibrium
with the exonic SNPs rs11318632 and rs4523. The first one was
associated with atopic asthma (Shin et al., 2003), and the latter
with adult asthma (Unoki et al., 2000) and atopic asthma in
children (Leung et al., 2002). A suggestive association between
rs8113232 in TBXA2R and rhinitis in asthmatic children has been
also reported (Kavalar et al., 2012). Finally, the TBXA2R 4684T
allele is associated with lower TBXA2R expression, which may
contribute to the development of NSAIDs-exacerbated cutaneous
disease (NECD) (Palikhe et al., 2011).
LTB4R1 and LTB4R2
Gene structure analysis of lung samples has revealed that both
LTB4R1 and LTB4R2 show splice variation in the 5′-UTR
and multiple promoter regions, although they did not find
susceptibility markers for asthma development (Tulah et al.,
2012). A previous study failed to associate polymorphisms
spanning the LTBR locus with baseline lung function in smokers
(Tulah et al., 2011).
Increased cytotoxicity and migration of NK cells appears
to be linked to LTB4 (Wang et al., 2015). However, there
is a differential role for its two receptors. Using a selective
receptor antagonist, LTB4R1 was shown to be involved in both
LTB4-induced migration and cytotoxicity, whereas LTB4R2 was
involved exclusively in NK cell migration, but only in response
to higher concentrations of LTB4. The expression of these two
receptors increased after activation of NK cells with IL-2 and IL-
15, and these changes in expression were reflected in enhanced
NK cell responses to LTB4 (Wang et al., 2015).
CYSLTR1 and CYSLTR2
The functional variant G300S in CYSLTR1 was associated with
atopy in the Tristan da Cunha population (Thompson et al.,
2007) as theM201V SNP inCYSLTR2was previously (Thompson
et al., 2003). TheG300S association has been replicated in another
study showing that LTD4-induced phosphorylation of Erk is
higher in transfected cells (Yaddaden et al., 2016).
Significant differences in genotype frequencies of the
CYSLTR1 promoter polymorphism −634C>T have been
associated with clinical requirement for leukotriene receptor
antagonists (Kim et al., 2007a). In addition, patients with the
variant genotype showed higher expression levels of CYSLTR1
than those with the common genotype (Kim et al., 2007a).
The rs320995 variant in CYSLTR1 has been associated with
asthma in two independent studies in Spain (Arriba-Mendez
et al., 2006; Sanz et al., 2006). Although a UK study involving
341 families could not find this association, it was linked to atopy
severity in females (Hao et al., 2006).
A significant association between the coding polymorphism
601A>G in CYSLTR2 and asthma was observed in a family-
based study of asthmatics from Denmark and USA, with the G
allele appearing to be less frequently transmitted to asthmatics
(Pillai et al., 2004). Using a calcium mobilization assay the
authors demonstrated that carriers of the G allele, LTD4 was
approximately five-fold less potent compared to wild type,
suggesting a potential mechanism for resistance to asthma (Pillai
et al., 2004).
A transmission disequilibrium test of 137 Japanese asthmatic
families showed that the −1220A>C SNP in CYSLTR2 was
associated with asthma development and with atopic asthma in
Japan (Fukai et al., 2004).
The mRNA and protein expression of CYSLT1R and CYSLT2R
was found to be significantly increased in polyp tissues from
eosinophilic chronic rhinosinusitis patients, and this increase was
shown to be related to LTC4 and LTD4 levels (Wu et al., 2016).
CYSLTR2 is expressed in the lungs of asthmatics and its activation
appears to contribute to antigen-induced bronchoconstriction in
certain asthma populations (Sekioka et al., 2015).
PTG, TBXA2, AND LT RECEPTOR
POLYMORPHISMS IN NSAID
HYPERSENSITIVITY
NSAIDs, commonly used in the treatment of pain and
some inflammatory diseases, are the main triggers of drug
hypersensitivity reactions (Conaghan, 2012). The most frequent
type of reaction caused by these drugs is cross-intolerance,
in which COX-1 inhibition leads to CysLTs release, resulting
in clinical symptoms in susceptible individuals (Doña et al.,
2011, 2012, 2014). Three main phenotypes of cross-intolerance
are currently recognized: NERD (previously known as aspirin-
induced asthma and ASA triad), in patients with rhinitis
and/or asthma with/without nasal polyposis; NECD (previously
known as aspirin-intolerant chronic urticaria), in patients with
underlying chronic idiopathic urticaria; and NSAIDs-induced
urticaria/angioedema (NIUA) in otherwise healthy individuals
(Kowalski et al., 2013).
Recent years have witnessed increased interest in the potential
role of SNPs in these pathologies. We will now focus on those
variants related to PTG and LT receptors.
PTGFR, PTGIR, PTGDR, and CRTH2
Most genetic association studies have not further investigated
the functional effects of associated variants, for example, the
1915T>C variant in PTGIR that has been associated with NERD
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in Korea, however the mechanisms by which it leads to the
pathology are unclear (Kim et al., 2007b).
Although the PTGDR −549T>C (rs8004654) SNP could
not been shown to be associated with NERD in a Korean
population (Kim et al., 2007b), we recently found an association
between NIUA, the most common type of drug hypersensitivity
reactions, and this polymorphism in two independent Spanish
populations (Cornejo-Garcia et al., 2012). In terms of potential
mechanism, it has been shown that the C allele (risk for
NIUA in our study) increases GATA-2/GATA-3 transcription
factor binding, modifying promoter activity and PTGDR gene
expression (Oguma et al., 2004). Interestingly, given that an
association could not be found in the Korean study mentioned
above, this variant has also been associated with NERD in Spain
(Ayuso et al., 2015).
In patients with NERD the CRTH2 −466T>C polymorphism
increases both serum and cellular eotaxin-2 production, and
may lead to eosinophilic infiltration in these patients (Palikhe
et al., 2010). Another study also showed that the frequency
of the homozygous genotype for the less frequent allele of
CRTH2 −466T>C was higher in NERD patients compared to
aspirin-tolerant asthmatics (Kohyama et al., 2012). Interestingly,
homozygous TT chronic urticaria patients required higher doses
of antihistamines (Palikhe et al., 2009).
PTGE Receptors
Two promoter variants (rs3810253 and rs3810255) in PTGER1
have recently been found to be associated with NERD, although
their functional consequences need to be elucidated (Ayuso et al.,
2015).
We have found that the rs1254598 polymorphism in PTGER2
was marginally associated with NERD patients when compared
with NSAID-tolerant asthmatics (Ayuso et al., 2015). In addition,
two promoter variants in PTGER2 (−616C>G and −166G>A)
have been associated with NERD in a Korean population (Kim
et al., 2007b).
It has been shown that in patients with NECD the GG
genotype at −1254G>A in PTGER4 is more frequent than in
healthy individuals (Palikhe et al., 2012). In addition, the G allele
leads to lower in vitro promoter activity with decreased PTGER4
expression (Palikhe et al., 2012). This promoter polymorphism
(−1254A>G) has also been reported to be associated with
NERD in Koreans (Kim et al., 2007b). However, recent research
failed to demonstrate an association between NIUA and two
promoter variants in PTGER4 (rs13186505 and rs4133101) in a
Spanish population (Cornejo-Garcia et al., 2012). In addition,
no statistically significant association was found for another
variant in PTGER4 (rs4495224) in NERD patients (Ayuso et al.,
2015).
TXA2R
The frequencies of the CC/CT genotype of TBXA2R 795T>C
were higher than those of the TT genotype in NERD patients
compared to ASA-tolerant asthmatics (Kohyama et al., 2012).
TBXA2R −4684C>T and 795T>C variants have also been
associated with NERD (Kim et al., 2007b).
CYSLTR1 and CYSLTR2
Male NERD patients showed higher frequencies of the minor
alleles of −634C>T, −475A>C, −336A>G polymorphisms in
CYSLTR1 than male controls (Kim et al., 2006). In addition,
the haplotype [T-C-G] was associated with increased disease
risk for NERD and also affected gene expression, measured by
significantly enhanced luciferase activity (Kim et al., 2006). The
−634C>T SNP was also most frequent in NERD compared to
NECD patients and the variant genotype showed significantly
higher promoter activity than the common genotype (Kim et al.,
2007c).
The CYSLTR1 variant rs320995 was associated with NIUA
in two independent Spanish populations (Cornejo-Garcia et al.,
2012). It has also been associated with NERD in Spain (Yaddaden
et al., 2016), but not with NERD in Korea (Choi et al., 2004).
Finally, NERD patients carrying the minor alleles for
819T>G, 2078C>T or 2534A>G in CYLSTR2 exhibited a more
pronounced fall in FEV1 after aspirin provocation than those
who carried the common allele (Park et al., 2005).
FUTURE DIRECTIONS
Important international efforts such as HapMap and the 1000
Genomes projects, as well as advances in in silico analysis have
led to substantial advances in our knowledge of the human
genome and its relationship with disease. This will almost
certainly increase in the near future through the adoption of next-
generation sequencing approaches for the discovery of associated
variants, and the integration of the different omics technologies,
such as transcriptomics, metabolomics, and lipidomics, which
will help us to uncover the underlying mechanisms behind
complex human diseases.
Focusing on GPCRs, a number of public databases integrating
genome data and in silico predictions are currently available
and have been recently reviewed (Thompson et al., 2014).
Four recommended computational tools for predicting the
functional effects of SNPs on protein structure and function are
PolyPhen (http://genetics.bwh.harvard.edu/pph2), SIFT (http://
sift.jcvi.org), SNAP (https://www.broadinstitute.org/mpg/snap),
and Mutation Taster (http://www.mutationtaster.org).
Mediators from the arachidonic acid pathway play a key role
in inflammation as well as in the pathogenesis of a number of
diseases. The lack of agreement in genetic association studies
is likely related to population differences, including ethnic
genetic background, sample size, and differences in phenotype
definitions. In addition, most genetic studies have not addressed
rare variants that are thought to be involved in complex
diseases together with environmental factors. In spite of these
limitations, as technologies improve and international networks
and collaborations continue to flourish, we expect our knowledge
on the genetic basis of inflammation and other conditions to
become more refined, potentially leading to the discovery of
markers and treatment options for a range of diseases.
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